This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Allscripts To Nominate Three New Independent Directors

CHICAGO and NEW YORK, June 1, 2012 /PRNewswire/ -- Allscripts Healthcare Solutions, Inc. (Allscripts – NASDAQ: MDRX) and HealthCor Management, L.P. ("HealthCor") today announced that Allscripts will nominate Stuart L. Bascomb, David D. Stevens and Randy Thurman as new independent directors for election to the Allscripts Board of Directors at the Company's 2012 Annual Meeting of Stockholders scheduled for June 15, 2012.  All three are highly-qualified professionals with significant expertise in the healthcare industry, each having previously served on the boards of directors of public companies and private organizations.

Allscripts and HealthCor also announced that, pursuant to their agreement, HealthCor will withdraw its claims against the Company currently pending in the Court of Chancery for the State of Delaware and will vote for all of the Company's nominees at the 2012 annual meeting. HealthCor currently owns approximately 6.1% of the outstanding shares of Allscripts' common stock.

Glen Tullman, Chief Executive Officer of Allscripts, said, "We welcome the addition of Stuart, David and Randy and believe they will bring new perspectives and additional industry experience to our board.  Taken together with the recent additions of Paul Black and Robert Cindrich, the Company will have added five, high-quality, independent directors in just the past few weeks.  We believe this is a positive outcome for Allscripts and its stockholders and we look forward to working collaboratively as we continue to implement our strategic initiatives and make the important and necessary investments to deliver a connected community of health for our clients and build value for all of our stockholders."

Arthur B. Cohen, co-founder and Portfolio Manager of HealthCor, said, "We are pleased to have reached this amicable resolution with Allscripts, which we believe will serve the best interests of all stockholders.  We continue to believe that Allscripts has great products, strong capabilities and a unique installed base of customers.  Furthermore, we are confident that Stuart, David and Randy will make strong additions to the Board, and will work hard to represent all stockholders and assist the Company in seizing the tremendous market opportunity before it."

In addition to the three new independent nominees, the Company's nine-member slate for election at the 2012 annual meeting will consist of: Paul Black, Dennis Chookaszian, Robert Cindrich, Philip Green, Michael Kluger and Glen Tullman.  Of the nine board members, eight are independent. 

Stockholders of record as of April 24, 2012 are entitled to vote at the Annual Meeting. 

Stuart L. Bascomb

Stuart Bascomb currently serves as the Chairman and Chief Executive Officer of QualSight, Inc., start-up company in Chicago to create a nationwide network of ophthalmologists to market a managed care refractive surgery program to plan sponsors.  Mr. Bascomb has a broad range of experience in the healthcare industry.  He was a founder of Express Scripts in 1986 and helped lead its IPO in 1992 as the company's CFO.  In addition, he served as Executive Vice President and Director at Express Scripts, Executive Vice President and Treasurer at Medicare-Glaser Corp. and Group Controller at Pet Incorporated. 

Mr. Bascomb is a current member of the American Institute of CPA's.  He served on the Board of Directors at St. Luke's Hospital and currently serves on its Strategic Planning Committee.  He also served on the Boards of a number of pharmaceutical industry and charitable organizations, including, the Strategic Development Board of the University of Missouri (Columbia) School of Business, the American Institute of CPA's, the Financial Executive Institute, where he served as Director of the St. Louis Chapter, Missouri March of Dimes, the Episcopal-Presbyterian Charitable Medical Trust, the Pharmaceutical Care Management Association and Past Chairman, the Chain Drug Industry's Accounting Principles Committee, the Chain Drug Industry's Administration and Operation. 

Mr. Bascomb received his M.A. in Accounting from the University of Missouri and his A.B. in Business Administration from William Jewell College.  

David D. Stevens

David Stevens is actively involved as an investor/advisor in private equity, focusing on providing capital to lower-middle market growth companies in the healthcare services industry.  Previously, Mr. Stevens served as Chief Executive Officer – AHG Division of Medco Health Solutions, Inc., where he was responsible, as the previous Chairman and Chief Executive Officer of Accredo Health Group, which was acquired by Medco, for the strategic direction and operation of the consolidated specialty pharmacy division of Medco (a reporting division of the parent), the largest specialty pharmacy provider in the market.  From Accredo Health's IPO in 1999 to 2005, Mr. Stevens grew the company's revenue from approximately $250 million to approximately $1.5 billion. Medco Health acquired Accredo in August 2005 for approximately $2.3 billion.  Prior to working at Accredo, he served as Chief Operating Officer at Southern Health Systems, Inc. and Vice-President and Chief Operating Officer at Le Bonheur Children's Medical Center. Stevens currently serves on the Board of Directors of Wright Medical Group, Inc., where he is the Chairman of the Board and member of the Governance, Compliance & Nominating Committee.  Previously, he served on the Boards of Medco Health Solutions, Inc. and Thomas & Betts Corporation, both public companies.

In addition, Mr. Stevens serves on the Board of Directors for three not-for-profit entities including Le Bonheur Children's Medical Center Foundation, Inc., Methodist Le Bonheur Health Systems, Inc., and The University of Tennessee Research Foundation. Mr. Stevens also actively serves on an advisory committee of the University Of Tennessee School Of Pharmacy.

Mr. Stevens received his MBA from Memphis State University and his B.S. in accounting from the University of Tennessee.

Randy Thurman

Randy Thurman currently serves as the Senior Advisor and Operating Partner at New Mountain Capital LLC, a leading private and public equity firm with assets in excess of $10 billion.  He has led or co-led transactions representing over $1 billion in enterprise value, and advised on private equity, public equity and debt transactions.  Mr. Thurman has held a number of executive positions throughout his career, including Founder, Chairman and Chief Executive Officer of Viasys Healthcare Inc., where from the company's IPO in 2001 to 2007, Mr. Thurman grew the company's revenues from approximately $350 million to approximately $700 million. Cardinal Health acquired Viasys in June 2007 for approximately $1.5 billion. In addition, Mr. Thurman served as Chairman and Chief Executive Officer of Strategic Reserves International, Chairman and Chief Executive Officer of Coming Life Sciences Inc., President, Chief Executive Officer and Board Director of Rhone-Poulenc Rorer Pharmaceuticals and various positions with Exxon Enterprises and Pepsico International.  Mr. Thurman also served as a fighter pilot for the United States Air Force.

Mr. Thurman has significant experience serving on the Boards of public companies and private organizations.  Most recently he served as the Chairman of the Board of Directors for public company, CardioNet.  Previously, he served on the Boards of Closure Medical Corporation, Curagen Inc. Rhone Poulenc Inc., Cooper Companies, Nichols Institute, Ikaria Inc., Hahneman University, High Flight of America, Corning Pharmaceutical Services, Metpath, Inc., Corning Life Sciences, Inc., Avantor, Performance Materials, and Rosenbluth International.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.42 -1.50%
FB $116.31 -0.36%
GOOG $692.92 0.27%
TSLA $239.51 -3.30%
YHOO $36.36 -0.63%


Chart of I:DJI
DOW 17,701.60 -129.16 -0.72%
S&P 500 2,059.78 -16.03 -0.77%
NASDAQ 4,765.0410 -40.25 -0.84%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs